Lowe Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $17.4K | Hold |
75
| – | – | 0.01% | 221 |
|
|
2025
Q2 | $13.9K | Hold |
75
| – | – | 0.01% | 230 |
|
|
2025
Q1 | $15.7K | Sell |
75
-20
| -21% | -$3.89K | 0.01% | 216 |
|
|
2024
Q4 | $16.9K | Buy |
95
+25
| +36% | +$4.6K | 0.01% | 199 |
|
|
2024
Q3 | $13.8K | Buy |
+70
| New | +$13.1K | 0.01% | 198 |
|
|
2023
Q2 | – | Sell |
-195
| Closed | -$31.1K | – | 355 |
|
|
2023
Q1 | $31.1K | Sell |
195
-280
| -59% | -$42.8K | 0.02% | 131 |
|
|
2022
Q4 | $76.8K | Hold |
475
| – | – | 0.04% | 84 |
|
|
2022
Q3 | $64K | Hold |
475
| – | – | 0.04% | 83 |
|
|
2022
Q2 | $73K | Sell |
475
-50
| -10% | -$7.64K | 0.04% | 73 |
|
|
2022
Q1 | $85K | Hold |
525
| – | – | 0.04% | 77 |
|
|
2021
Q4 | $71K | Hold |
525
| – | – | 0.03% | 81 |
|
|
2021
Q3 | $57K | Sell |
525
-100
| -16% | -$11.4K | 0.03% | 85 |
|
|
2021
Q2 | $70K | Buy |
625
+250
| +67% | +$28.2K | 0.03% | 74 |
|
|
2021
Q1 | $41K | Hold |
375
| – | – | 0.02% | 97 |
|
|
2020
Q4 | $40K | Hold |
375
| – | – | 0.02% | 95 |
|
|
2020
Q3 | $33K | Hold |
375
| – | – | 0.02% | 92 |
|
|
2020
Q2 | $37K | Sell |
375
-35
| -9% | -$3.08K | 0.02% | 81 |
|
|
2020
Q1 | $31K | Hold |
410
| – | – | 0.02% | 79 |
|
|
2019
Q4 | $36K | Sell |
410
-150
| -27% | -$12.5K | 0.02% | 82 |
|
|
2019
Q3 | $42K | Buy |
560
+100
| +22% | +$6.86K | 0.03% | 69 |
|
|
2019
Q2 | $33K | Buy |
460
+310
| +207% | +$24.4K | 0.02% | 87 |
|
|
2019
Q1 | $12K | Hold |
150
| – | – | 0.01% | 131 |
|
|
2018
Q4 | $14K | Hold |
150
| – | – | 0.01% | 117 |
|
|
2018
Q3 | $14K | Hold |
150
| – | – | 0.01% | 128 |
|
|
2018
Q2 | $14K | Hold |
150
| – | – | 0.01% | 121 |
|
|
2018
Q1 | $14K | Hold |
150
| – | – | 0.01% | 130 |
|
|
2017
Q4 | $15K | Sell |
150
-50
| -25% | -$4.71K | 0.01% | 130 |
|
|
2017
Q3 | $18K | Hold |
200
| – | – | 0.01% | 117 |
|
|
2017
Q2 | $15K | Hold |
200
| – | – | 0.01% | 110 |
|
|
2017
Q1 | $13K | Hold |
200
| – | – | 0.01% | 119 |
|
|
2016
Q4 | $13K | Hold |
200
| – | – | 0.01% | 119 |
|
|
2016
Q3 | $13K | Hold |
200
| – | – | 0.01% | 126 |
|
|
2016
Q2 | $12K | Buy |
200
+50
| +33% | +$3.05K | 0.01% | 125 |
|
|
2016
Q1 | $9K | Hold |
150
| – | – | 0.01% | 131 |
|
|
2015
Q4 | $9K | Hold |
150
| – | – | 0.01% | 132 |
|
|
2015
Q3 | $8K | Buy |
+150
| New | +$9.76K | 0.01% | 138 |
|
Other funds holding ABBV
Lowe Wealth Advisors's ABBV Position: Q3 2025 in Review
Lowe Wealth Advisors held its AbbVie (ABBV) position steady in Q3 2025 at 75 shares worth $17.4K. The position accounts for 0.01% of the portfolio, ranked #221.
Lowe Wealth Advisors first reported a position in ABBV in Q3 2015 and has held it in 36 quarters since. The position peaked at $85K in Q1 2022. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Lowe Wealth Advisors held 75 shares of AbbVie worth $17.4K as of Q3 2025.
- Lowe Wealth Advisors left its AbbVie share count unchanged in Q3 2025.
- AbbVie made up 0.01% of Lowe Wealth Advisors's portfolio in Q3 2025, its #221 holding.
- Lowe Wealth Advisors first reported a position in AbbVie in Q3 2015 and has held it in 36 quarters since.
- Lowe Wealth Advisors's AbbVie position peaked at $85K in Q1 2022.
- 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Lowe Wealth Advisors's 13F filing for Q3 2025, filed 16 Oct 2025.